PainReform Ltd. Ordinary Shares earnings per share and revenue
On --, PRFX reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to -- --, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
What were PainReform Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q-- --?
For Q-- --, PainReform Ltd. Ordinary Shares reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to PainReform Ltd. Ordinary Shares's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is PainReform Ltd. Ordinary Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for PainReform Ltd. Ordinary Shares's next earnings report?
Based on --
analistas, PainReform Ltd. Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.